Quercetin, myricetin |
Protection of cancer cells against hydrogen peroxide |
Caco-2 and HepG2 |
[35, 36] |
Quercetin |
Decrease the activity of oxygen radical |
Human hepatocellular carcinoma (HepG2) |
[37–39] |
AgNPs and natural bioactive compounds |
Represent novel therapeutics fighting and synergistic, antimicrobial effects |
Epithelioma papulosum cyprini (EPC) cell lines |
[40] |
Dietary polyphenols |
Inducing cell cycle arrest or apoptosis, metastasis, and angiogenesis |
Colorectal cancer cell lines |
[41] |
Fucoidan |
Nuclear fragmentation, and mitochondrial potential loss, ROS generation |
HaCaT (immortal noncancerous keratinocyte), HeLa (epithelial adenocarcinoma cells of the cervix) |
[27] |
Liquid crystalline nanoparticles |
Inhibited the genes, namely, Nox2B and Nox4, which caused oxidative stress, upregulation in the expression of the antioxidant genes Gclc and Nqo-1
|
Human bronchial epithelial cells (BEAS-2B) |
[36, 42] |
Quercetin |
Reduce the enzymes precarcinogenic compounds such as CYP1A |
Intestinal HCT‐8 Cells |
[38, 42] |
Diosmin and Tangeretin |
Antimetastatic effects |
Melanoma B16F10 cancer cells |
[43] |
Zinc(II) flavonoid-metal complex |
Modulated expression of genes related to angiogenesis, cell cycle progression |
Leukaemia (KG1, K562, and Jurkat), melanoma (B16F10 and SK-Mel-28), and multiple myeloma (RPMI8226) cell lines |
[44] |
Ionic liquids nanoparticles |
Caused a significant increase in the sub-G1 population, a significant decrease in cell viability |
Human renal cancer cell line (786-O) |
[45] |
Silibinin |
Anticancer, apoptosis effects regulating the expressions of genes apoptosis, inflammation, and MAPK pathway proteins |
Human colon cancer cell line |
[46] |
Poly (D, L-lactic-co-glycolic acid) (PLGA) nanospheres, Benzamide |
Cell cycle disruption and apoptotic induction |
MDA-MB-231 |
[47] |